Treace Medical Concepts, Inc. (TMCI) Misses Q1 EPS by 3c, Beats on Revenue; Lowers FY24 Revenue Guidance

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.30), $0.03 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $51.1 million versus the consensus estimate of $49.07 million.

GUIDANCE:

Treace Medical Concepts, Inc. lowers guidance range for full-year 2024, expecting revenues of $201 million to $211 million from $220 million to $225 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• ASML Holdings (ASML) Tops Q2 EPS by 59c; offers guidance
• Citizens Starts Knight Transportation (KNX) at Market Outperform
• Citizens Starts FedEx Freight Holding Company (FDXF) at Market Outperform